Biobanks Market by Component, Sample Type, Application

List of Tables

The Biobanks Market was valued at USD 67.81 billion in 2023, expected to reach USD 75.75 billion in 2024, and is projected to grow at a CAGR of 11.80%, to USD 148.10 billion by 2030.

Biobanks are crucial repositories that collect and store biological samples such as blood, cells, tissues, and DNA, predominantly for research and medical advancements. Their necessity is underscored by the increasing demand for personalized medicine and genomic research, as they provide critical data for studies on disease progression, drug development, and biomarker discovery. The application of biobanks spans across academic research institutions, pharmaceutical companies, and hospital settings, with a growing end-use scope in personalized healthcare, cancer research, and regenerative medicine. The market for biobanks is influenced by factors such as advances in genomic technologies, government funding for biobanking projects, and growing investments by biopharma companies in drug discovery initiatives. The latest potential opportunities lie in the integration of digital technologies like artificial intelligence and blockchain for data management and security-allowing more efficient sample tracking and usage, which can significantly enhance research outputs. Challenges include ethical concerns over data privacy, high costs associated with biobank management, and regulatory complexities which can impede market growth. There are also concerns over sample storage quality and standardization across biobanking facilities. To overcome these challenges, innovation can be directed towards improving cryopreservation techniques and developing standardized protocols for sample collection and storage to ensure high-quality and reproducible sample data. Additionally, collaborative networks among biobanks can facilitate the sharing of resources and knowledge, fostering advancements in research and development. The market is characterized by high competition and rapid technological evolution, necessitating continuous investment in R&D to maintain cutting-edge capabilities. Overall, the biobank market holds significant potential for growth driven by technological integration and a growing emphasis on personalized medicine, with strategic collaborations and enhanced data security being pivotal for success.

KEY MARKET STATISTICS
Base Year [2023]	USD 67.81 billion
Estimated Year [2024]	USD 75.75 billion
Forecast Year [2030]	USD 148.10 billion
CAGR (%)	11.80%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biobanks Market

The Biobanks Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

Market Drivers
- Increase in incidence of chronic disease
- Rising awareness about biobanks
- Increasing population coupled with presence of a large geriatric population base
Market Restraints
- Ethical and legal issues related to biobanking
Market Opportunities
- Growing genomic research activities in economies
- Increasing public awareness about genomic testing and stem cell therapies
Market Challenges
- Long-Term Sustainability of Biobanks

Porter's Five Forces: A Strategic Tool for Navigating the Biobanks Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biobanks Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biobanks Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biobanks Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biobanks Market

A detailed market share analysis in the Biobanks Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biobanks Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biobanks Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biobanks Market

A strategic analysis of the Biobanks Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biobanks Market, highlighting leading vendors and their innovative profiles. These include Acorn Biolabs, Inc., Artizan Biosciences, Inc., Bay Biosciences LLC, Beckman Coulter, Inc. by Danaher Corporation, Becton, Dickinson and Company, BioLife Solutions Inc., LVL Technologies GmbH & Co. KG, Merck KGaA, ProteoGenex, Inc., Provia Laboratories, LLC, Shanghai Zhangjiang Biobank, Taylor-Wharton, Tecan Trading AG, Thermo Fisher Scientific Inc., and UK Biobank Limited.

Market Segmentation & Coverage

This research report categorizes the Biobanks Market to forecast the revenues and analyze trends in each of the following sub-markets:

Based on Component, market is studied across Consumables, Equipment, Services, and Software.
Based on Sample Type, market is studied across Biological Fluids, Blood Products, Cell Lines, Human Tissues, and Nucleic Acids.
Based on Application, market is studied across Clinical Research, Life Science Research, and Regenerative Medicine.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Product Code: MRR-437D4595886E

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Increase in incidence of chronic disease
  - 5.1.1.2. Rising awareness about biobanks
  - 5.1.1.3. Increasing population coupled with presence of a large geriatric population base
- 5.1.2. Restraints
  - 5.1.2.1. Ethical and legal issues related to biobanking
- 5.1.3. Opportunities
  - 5.1.3.1. Growing genomic research activities in economies
  - 5.1.3.2. Increasing public awareness about genomic testing and stem cell therapies
- 5.1.4. Challenges
  - 5.1.4.1. Long-Term Sustainability of Biobanks
5.2. Market Segmentation Analysis
5.3. Porter's Five Forces Analysis
- 5.3.1. Threat of New Entrants
- 5.3.2. Threat of Substitutes
- 5.3.3. Bargaining Power of Customers
- 5.3.4. Bargaining Power of Suppliers
- 5.3.5. Industry Rivalry
5.4. PESTLE Analysis
- 5.4.1. Political
- 5.4.2. Economic
- 5.4.3. Social
- 5.4.4. Technological
- 5.4.5. Legal
- 5.4.6. Environmental

6. Biobanks Market, by Component

6.1. Introduction
6.2. Consumables
6.3. Equipment
6.4. Services
6.5. Software

7. Biobanks Market, by Sample Type

7.1. Introduction
7.2. Biological Fluids
7.3. Blood Products
7.4. Cell Lines
7.5. Human Tissues
7.6. Nucleic Acids

8. Biobanks Market, by Application

8.1. Introduction
8.2. Clinical Research
8.3. Life Science Research
8.4. Regenerative Medicine

9. Americas Biobanks Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Biobanks Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Biobanks Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.4. Strategy Analysis & Recommendation

Companies Mentioned

1. Acorn Biolabs, Inc.
2. Artizan Biosciences, Inc.
3. Bay Biosciences LLC
4. Beckman Coulter, Inc. by Danaher Corporation
5. Becton, Dickinson and Company
6. BioLife Solutions Inc.
7. LVL Technologies GmbH & Co. KG
8. Merck KGaA
9. ProteoGenex, Inc.
10. Provia Laboratories, LLC
11. Shanghai Zhangjiang Biobank
12. Taylor-Wharton
13. Tecan Trading AG
14. Thermo Fisher Scientific Inc.
15. UK Biobank Limited